SCHEMBL7804346

SCHEMBL7804346

O=C(O)CCCOc1ccc(N2CCN(C(=O)c3cccc4ccccc34)CC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.56
MAPT P10636 5/20 0.56
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
KDM4E B2RXH2 3/20 0.55
HIF1A Q16665 1/20 0.55
POLB P06746 2/20 0.54
USP2 O75604 2/20 0.51
DRD3 P35462 1/20 0.51
HRH3 Q9Y5N1 1/20 0.51
TSHR P16473 2/20 0.50
GAA P10253 1/20 0.50
LMNA P02545 3/20 0.49
HSD17B10 Q99714 2/20 0.49
HTT P42858 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
GCGR P47871 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7804694 0.96 ALDH1A1 (0.56) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL7813512 0.90 MAPT (0.55) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL3579223 0.89 ALDH1A1 (0.58) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL7817501 0.89 ALDH1A1 (0.64) ALDH1A1MAPTRAB9AMEN1KMT2A
SCHEMBL7804363 0.86 ALDH1A1 (0.54) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL9011169 0.84 ALDH1A1 (0.57) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL13437970 0.84 GCGR (0.67) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL6472173 0.84 GCGR (0.67) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL13437969 0.84 GCGR (0.67) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL13437978 0.84 GCGR (0.67) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed